Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases March 20, 2023 RG6501 (OpRegen®) Phase 1/2a Clinical Results to Be Presented at 2023 Retinal Cell and Gene Therapy Innovation Summit March 09, 2023 Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update March 06, 2023 RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Eyal Banin, M.D., Ph.D. VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview January 23, 2023 5.4 MB Roche’s Pharma Day 2022 Fourth Quarter 2022 Financial Results Earnings Call Mar 9, 2023 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
March 20, 2023 RG6501 (OpRegen®) Phase 1/2a Clinical Results to Be Presented at 2023 Retinal Cell and Gene Therapy Innovation Summit
March 09, 2023 Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 06, 2023 RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Eyal Banin, M.D., Ph.D.
Fourth Quarter 2022 Financial Results Earnings Call Mar 9, 2023 at 4:30 PM EST Click here for webcast
